Novartis appeals IP win for Pharmacor over blood pressure drug

SYDNEY: Pharmaceutical giant Novartis is challenging the loss of its case against generics company Pharmacor

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In